In 2026, Ripple secured major institutional deals including a tokenized U.S. Treasury settlement with JPMorgan and Mastercard, expanded partnerships with Deutsche Bank, and launched its RLUSD stablecoin in Japan. Despite these wins, XRP's price remains weak near $1, as most institutional transactions use RLUSD, not XRP, for settlement due to XRP's volatility. This structural shift means Ripple's corporate success benefits the ledger and stablecoin more than the token itself. XRP's price may rise only if large-scale, recurring XRP demand emerges, alongside regulatory clarity and stronger fund inflows.
Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...
Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...
Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...
Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...
Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...
